On average, Tiam1 expression levels were 3.75-fold higher in prostate cancer and 3.6-fold higher in HG-PIN lesions, respectively, than in the corresponding benign secretory epithelial cells (Figure 1C). This evidence concerns the gene TIAM1 and prostate carcinoma.